Hardy E
Giugliano, Insulin and glucagon-like peptide 1 receptor agonist combination therapy in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
We asked a number of important questions regarding available weight loss treatments, cost, insurance, and what there is to know about the nutrition program
During the 26- to 78-week treatment periods in 5 clinical trials in adults with type 2 diabetes mellitus [see Clinical Studies (14.2, 14.3)] and 1 clinical trial in Japanese adults with type 2 diabetes mellitus, 14/2,924 (0.5%) of semaglutide tablet-treated patients developed anti-semaglutide antibodies
The Food and Drug Administration (FDA) has warned the public about taking unapproved versions of weight-loss drugs that do not undergo the FDAs review for safety, effectiveness, and quality before they are marketed
However, any conclusions drawn from these cases may be limited by inability to isolate the positive mental health effects of tirzepatide (as tirzepatide was administrated concurrently with psychotropic medications) and other unidentified factors that may have impacted mood
.webp)
